These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35097030)

  • 1. Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients.
    Yao Y; Liu J; Wang B; Zhou Z; Lu X; Huang Z; Deng J; Yang Y; Tan N; Chen S; Chen J; Liu Y
    Front Cardiovasc Med; 2021; 8():817442. PubMed ID: 35097030
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic impact of lipoprotein(a) in patients undergoing percutaneous coronary intervention modified by low density lipoprotein cholesterol.
    Xu N; Yuan D; Yao Y; Jiang L; Xu J; Tang X; Song Y; Gao L; Chen J; Song L; Zhao X; Chen J; Yang Y; Xu B; Gao R; Yuan J
    Clin Chim Acta; 2023 Feb; 540():117217. PubMed ID: 36610466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Rikhi R; Hammoud A; Ashburn N; Snavely AC; Michos ED; Chevli P; Tsai MY; Herrington D; Shapiro MD
    Atherosclerosis; 2022 Dec; 363():102-108. PubMed ID: 36253168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
    Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
    Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
    Puri R; Ballantyne CM; Hoogeveen RC; Shao M; Barter P; Libby P; Chapman MJ; Erbel R; Arsenault BJ; Raichlen JS; Nissen SE; Nicholls SJ
    Atherosclerosis; 2017 Aug; 263():137-144. PubMed ID: 28641153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels.
    Xu W; Guan H; Gao D; Wang Z; Ba Y; Yang H; Shen W; Lian J; Zhou J
    Diabetes Metab Syndr Obes; 2020; 13():4297-4310. PubMed ID: 33209043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
    Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
    J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial.
    Yu Q; Xue Q; Liu H; Hu J; Wang R; Song Y; Zhou Y; Zhang W; Zhu Y; Zhao Q
    Front Cardiovasc Med; 2023; 10():1103681. PubMed ID: 37034344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes.
    Gencer B; Rigamonti F; Nanchen D; Vuilleumier N; Kern I; Aghlmandi S; Klingenberg R; Räber L; Auer R; Carballo D; Carballo S; Heg D; Windecker S; Lüscher TF; Matter CM; Rodondi N; Mach F
    Eur J Clin Invest; 2019 Jul; 49(7):e13117. PubMed ID: 30937890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels.
    Xu J; Hao X; Zhan R; Jiang X; Jin A; Xue J; Cheng A; Liu J; Lin J; Meng X; Li H; Zheng L; Wang Y
    Stroke; 2022 Aug; 53(8):2504-2511. PubMed ID: 35410491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
    Nakamura H; Kataoka Y; Nicholls SJ; Puri R; Kitahara S; Murai K; Sawada K; Matama H; Iwai T; Honda S; Fujino M; Takagi K; Yoneda S; Otsuka F; Nishihira K; Asaumi Y; Tsujita K; Noguchi T
    Atherosclerosis; 2022 May; 349():183-189. PubMed ID: 35450750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lipoprotein(a) and fibrinogen on prognosis in patients with coronary artery disease: A retrospective cohort study.
    Liang D; Liang D; Liu J; Zheng Y; Huang D; Li Z; Huang X; Chen J
    Technol Health Care; 2024; 32(5):3317-3328. PubMed ID: 38848204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malnutrition affects cholesterol paradox in coronary artery disease: a 41,229 Chinese cohort study.
    Wang B; Liu J; Chen S; Ying M; Chen G; Liu L; Lun Z; Li H; Huang H; Li Q; Yu Y; Lin M; Wei W; Huang Z; Yang Y; Chen J; Tan N; Liu Y
    Lipids Health Dis; 2021 Apr; 20(1):36. PubMed ID: 33874960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a).
    Maher VM; Brown BG; Marcovina SM; Hillger LA; Zhao XQ; Albers JJ
    JAMA; 1995 Dec; 274(22):1771-4. PubMed ID: 7500507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) as a Higher Residual Risk for Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus than without.
    Yu B; Hu X; Liu J; Nie Z; Ren Luo Bu C; Li G; Zhou Y; Dong H
    Int J Gen Med; 2023; 16():3383-3391. PubMed ID: 37576912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-HDL cholesterol paradox and effect of underlying malnutrition in patients with coronary artery disease: A 41,182 cohort study.
    Wang B; Guo Z; Li H; Zhou Z; Lu H; Ying M; Mai Z; Yu Y; Yang Y; Deng J; Chen J; Tan N; Liu J; Liu Y; Chen S
    Clin Nutr; 2022 Mar; 41(3):723-730. PubMed ID: 35168005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
    Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.